Please Download Flash

Browse News by Year:
  RSS
News Highlights:

Ironwood and Collaborators Present Preclinical Data Demonstrating that Cyclic GMP Alleviates Intestinal Pain--Data Presented at ACG Annual Scientific Conference

October 6, 2008 - View Full Article

Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator™ Drugs

August 25, 2008 - Proteostasis Therapeutics, Inc. (PTI) today announced that it has secured $45 million in a Series A financing led by Fidelity Biosciences. View Full Article

ProteoStasis Therapeutics: Cultivating the next Big Idea company

August 24, 2008 - Boston.com discusses Fidelity Biosciences' recent investment in ProteoStasis Therapeutics. View Full Article

WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development

August 1, 2008 - August 1, 2008 – Shanghai, China – WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has appointed Mr. Steven M. Hutchins as Vice President of Business Development. View Full Article

U.S. Genomics Awarded $9.1 Million Contract for Development of Advanced Biosensor by the U.S. Department of Homeland Security

July 16, 2008 - U.S. Genomics today announced the award of a $9.1 million contract by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate. View Full Article

Accuri Cytometers Completes $13 Million Series C Financing

July 8, 2008 - Accuri Cytometers Inc., a life sciences company developing revolutionary bench-top flow cytometer systems, today announced the completion of a $13 million Series C financing led by Fidelity Biosciences and Flagship Ventures. View Full Article

FoldRx Technology Enables Discovery of Novel Therapeutic Approach for Treating Cystic Fibrosis

July 8, 2008 - FoldRx Pharmaceuticals, Inc. (FoldRx) today announced that it has discovered a series of novel drug prototypes that have shown potential in vitro to correct the protein-folding defect associated with cystic fibrosis (CF). View Full Article

Intranasal Therapeutics Names Jeffrey Edelson, MD,

July 8, 2008 - Intranasal Therapeutics, Inc. (ITI), a specialty pharmaceutical company focused on developing nasally delivered, preservative-free drug products, today announced a key executive addition to the company’s leadership team. Jeff Edelson, MD, previously employed by Johnson & Johnson (J&J) as Vice President, Internal Medicine and Therapeutic Area Head - Novel Therapeutics, has joined ITI as Executive Vice President, R&D, and Chief Medical Officer. View Full Article

Accuri Cytometers Inc. to Distribute FCS Express

June 27, 2008 - De Novo Software, a leading provider of flow cytometry data analysis solutions, and Accuri Cytometers, a privately held manufacturer of innovative benchtop flow cytometry systems, announced today that they have entered into a licensing agreement providing for Accuri to distribute a customized version of De Novo Software's flagship product, FCS Express, with every Accuri C6 Flow Cytometer System. View Full Article

Transave Announces Positive Phase II Results for Once-Daily Arikace™ in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections

June 13, 2008 - Transave, Inc., today reported positive results from a Phase II clinical trial on its lead investigational drug, Arikace™ (liposomal amikacin for inhalation). The compound is being developed for the treatment of cystic fibrosis (CF) patients who have lung infections... View Full Article

U.S. Genomics Recognized for Outstanding Entrepreneurship

June 12, 2008 - U.S. Genomics Inc, a pioneer of single molecule biology technologies for the biodefense and life sciences industries, has been recognized by the NSF for outstanding entrepreneurship at its May NSF SBIR /STTR (Small Business Innovation Research/Small Business Technology Transfer) Phase II Grantee Conference. View Full Article

Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.

February 12, 2008 - Mersana, a cancer therapeutics company, announced today that Timothy B. Lowinger, Ph.D., has joined the company as Chief Scientific Officer. View Full Article

Methygene Exercises Right to Opt-Out of HDAC Neurodegenerative Collaboration with Envivo

February 6, 2008 - MethylGene Inc. (TSX:MYG) and EnVivo Pharmaceuticals today announced that MethylGene has exercised its right to opt-out of further funding in its collaboration with EnVivo signed in February 2005. EnVivo will continue to research and develop... View Full Article

Dr. Manuel Worcel Appointed CEO and President of Cardiokine

January 22, 2008 - Cardiokine, Inc., a privately held specialty pharmaceutical company focused on the development of drugs for the treatment of heart failure and related indications, today announced that Dr. Manuel Worcel has been appointed President and Chief Executive Officer. View Full Article

ViewRay Incorporated Raises $25 Million in Series B Financing

January 21, 2008 - ViewRay Incorporated (http://www.viewray.com/), a medical device manufacturer, announced today the close of a $25 million Series B financing. Founded in 2004, ViewRay Incorporated is focused on the development of a real-time magnetic resonance imaging (MRI)... View Full Article

Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors

January 3, 2008 - Mersana, a cancer therapeutics company, announced today the appointment of C. Boyd Clarke as Chairman of the Company’s Board of Directors. Mr. Clarke is a senior biotechnology and pharmaceutical executive with a significant record of accomplishment over a 30-year industry career. View Full Article